Kevin S Baker

Kevin S Baker

Takeda Pharmaceutical Company Limited - Osaka / Japan
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4769754
武田薬品工業株式会社
person_outline Kevin S Baker's MOST POPULAR ARTICLES
1-) Von Willebrand factor delays liver repair after acetaminophen-induced acute liver injury in miceD Groeneveld, H Cline-Fedewa, KS Baker, KJ Williams, RA Roth, ...Journal of hepatology 72 (1), 146-155, 2020272020
2-) Chronic liver injury drives non‐traditional intrahepatic fibrin (ogen) crosslinking via tissue transglutaminaseLG Poole, A Pant, KS Baker, AK Kopec, HM Cline‐Fedewa, SE Iismaa, ...Journal of Thrombosis and Haemostasis 17 (1), 113-125, 2019132019
3-) Factor XIII cross-links fibrin (ogen) independent of fibrin polymerization in experimental acute liver injuryLG Poole, AK Kopec, DJ Groeneveld, A Pant, KS Baker, ...Blood, The Journal of the American Society of Hematology 137 (18), 2520-2531, 2021132021
4-) Plasminogen activator inhibitor-1 reduces tissue-type plasminogen activator–dependent fibrinolysis and intrahepatic hemorrhage in experimental acetaminophen overdoseA Pant, AK Kopec, KS Baker, H Cline-Fedewa, DA Lawrence, ...The American Journal of Pathology 188 (5), 1204-1212, 2018132018
5-) Direct amplification of tissue factor: factor VIIa procoagulant activity by bile acids drives intrahepatic coagulationKS Baker, AK Kopec, A Pant, LG Poole, H Cline-Fedewa, D Ivkovich, ...Arteriosclerosis, thrombosis, and vascular biology 39 (10), 2038-2048, 2019122019